Table 4.
The risk of OIs and HIV-associated malignancies on mortality among WLHIV in Ethiopia (2007–2019).
| OI or HIV-related malignancy | P-value | AHR | 95% CI | |
|---|---|---|---|---|
| Lower | Upper | |||
| Oral candidiasis | ||||
| Yes | 0.00 | 1.21 | 1.04 | 1.98 |
| No | Ref. | |||
| Herpes zoster | ||||
| Yes | 0.02 | 1.32 | 1.04 | 1.69 |
| No | Ref. | |||
| Pneumocystis pneumonia (PCP) | ||||
| Yes | 0.01 | 1.39 | 1.21 | 2.32 |
| No | Ref. | |||
| Toxoplasmosis | ||||
| Yes | 0.00 | 2.14 | 1.34 | 3.41 |
| No | Ref. | |||
| Tuberculosis | ||||
| Yes | 0.00 | 2.11 | 1.72 | 2.59 |
| No | Ref. | |||
| Cervical cancer | ||||
| Yes | 0.30 | 1.12 | 0.89 | 1.41 |
| No | Ref. | |||
| Lymphoma | ||||
| Yes | 0.00 | 1.54 | 1.26 | 1.90 |
| No | Ref. | |||